Redox regulation by thioredoxin superfamily; protection against oxidative stress and aging
- 1 January 2000
- journal article
- review article
- Published by Taylor & Francis in Free Radical Research
- Vol. 33 (6) , 851-855
- https://doi.org/10.1080/10715760000301361
Abstract
Thioredoxin (TRX) is a 12 kD protein with redox-active dithiol in the active site; -Cys-Gly-Pro-Cys-. We originally cloned human TRX as adult T cell leukemia derived factor (ADF) produced by HTLV-I transformed cells. TRX and related molecules maintain a cellular reducing environment, working in concert with the glutathione system. Physiologically, TRX has cytoprotective effects against oxidative stress. TRX promotes DNA binding of transcription factors such as NF-kB, AP-1, p53, and PEBP-2. The TRX superfamily, including thioredoxin-2 (mitochondrial thioredoxin) and glutaredoxin, are involved in biologically important phenomena via the redox-regulating system. Thioredoxin-binding protein-2, which we recently identified by a yeast two-hybrid system, is a type of endogenous modulator of TRX activity. TRX is secreted from the cells and exhibits cytokine-like and chemokine-like activities. Redox regulation by TRX plays a crucial role in biological responses against oxidative stress.Keywords
This publication has 17 references indexed in Scilit:
- Thioredoxin, a Redox Enzyme Released in Infection and Inflammation, Is a Unique Chemoattractant for Neutrophils, Monocytes, and T CellsThe Journal of Experimental Medicine, 1999
- Mouse glutaredoxin — cDNA cloning, high level expression inE. coliand its possible implication in redox regulation of the DNA binding activity in transcription factor PEBP2Free Radical Research, 1999
- Pancreatic β Cell–specific Expression of Thioredoxin, an Antioxidative and Antiapoptotic Protein, Prevents Autoimmune and Streptozotocin-induced DiabetesThe Journal of Experimental Medicine, 1998
- Thioltransferase (Glutaredoxin) Reactivates the DNA-binding Activity of Oxidation-inactivated Nuclear Factor IJournal of Biological Chemistry, 1998
- Cloning and Expression of a Novel Mammalian ThioredoxinJournal of Biological Chemistry, 1997
- Attenuation of ischaemia reperfusion injury by human thioredoxin.Thorax, 1995
- Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxideImmunology Letters, 1994
- Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1994
- Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulationImmunology Today, 1992
- Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.Proceedings of the National Academy of Sciences, 1990